All News

Characterisation

Ensuring a Robust Supply of Biomaterials to Meet a Growing Industry
30 December 2021
Ensuring a Robust Supply of Biomaterials to Meet a Growing Industry
Interview - Q&A
Risk-Based Assay Development Strategies for Cell Therapies
24 June 2021
Risk-Based Assay Development Strategies for Cell Therapies
Getting a cell or cell-based
Reproducibility, Reliability, Robustness: Establishing Cornerstones for Standardisation Of Cell Manufacturing
27 May 2020
Reproducibility, Reliability, Robustness: Establishing Cornerstones for Standardisation Of Cell Manufacturing
Reproducibility, Reliability, Robustness: Establishing Cornerstones for Standardisation Of Cell Manufacturing
27 May 2020
Reproducibility, Reliability, Robustness: Establishing Cornerstones for Standardisation Of Cell Manufacturing
Which manufacturing parameters have significant
POPULAR NEWS ITEMS
Image
11 August 2022

GentiBio Collab with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for IBD

Image
10 August 2022

Stevenage Bioscience Hub’s Lab Hotel Joined by Inspira Pharmaceuticals

Image
9 August 2022

Pfizer Acquire Global Blood Therapeutics for $5.4 Billion

What’s Next for Commercial Cell Therapy Manufacturing?
15 March 2019
What’s Next for Commercial Cell Therapy Manufacturing?
Video - On Demand Library
RECOMENDED TOPICS
Automation & Digitisation
Characterisation
CMC
GMP
Logistics
Partnering
Point of Care
Raw Materials
Scaling Up
Skills, Talent & Development
Supply Chain
POPULAR NEWS ITEMS
Image

GentiBio Collab with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for IBD

Image

Stevenage Bioscience Hub’s Lab Hotel Joined by Inspira Pharmaceuticals

Image

Pfizer Acquire Global Blood Therapeutics for $5.4 Billion